10x Genomics (NASDAQ: TXG)
10x Genomics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
10x Genomics Company Info
10x Genomics' Chromium platform empowers researchers to examine the full complexity of diverse cells.
News & Analysis
Why 10x Genomics Stock Was Sliding This Week
Investing in Genetic Sequencing Stocks
10x Genomics Misses Revenue Forecast
10x Genomics reported declining revenue and lowered its financial guidance amidst ongoing market pressures.
10x Genomics Cuts 2024 Revenue Outlook as Q2 Sales Miss Estimates
10x Genomics revenue growth fell short of estimates and management lowered its full-year forecast.
Got $2,000? Consider Buying These 2 Beaten-Down Cathie Wood Stocks at Your Own Risk
Their long-term plans are ambitious, but they haven't performed well as investments recently.
3 Cathie Wood Stocks That Could Deliver Monster Returns
Here's why our roundtable likes 10x Genomics, Beam Therapeutics, and Recursion Pharmaceuticals.
My Favorite Biotech
Here's why three Fool.com contributors love 10x Genomics, Axsome Therapeutics, and Doximity.
3 Unstoppable Stocks That Could Soar 58% to 97%, According to Wall Street
Analysts think the downturns for these stocks should only be temporary.
Valuation
Podcast Episodes
Earnings Transcripts
10X Genomics Inc (TXG) Q3 2021 Earnings Call Transcript
TXG earnings call for the period ending September 30, 2021.
10x Genomics Inc (TXG) Q1 2020 Earnings Call Transcript
TXG earnings call for the period ending March 31, 2020.
10x Genomics Inc (TXG) Q4 2019 Earnings Call Transcript
TXG earnings call for the period ending December 31, 2019.
10x Genomics Inc (TXG) Q3 2019 Earnings Call Transcript
TXG earnings call for the period ending September 30, 2019.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.